Enanta Pharmaceuticals Inc (ENTA) financials · rev $65.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Enanta Pharmaceuticals Inc (ENTA) rev $65.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $65.3M | $67.6M |
| Operating Income | -$85.3M | -$121.7M |
| Net Income | -$81.9M | -$116.0M |
| EPS (Diluted) | -$3.84 | -$5.48 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $280.7M | $376.7M |
| Current Assets | $204.3M | $299.9M |
| Cash & Equivalents | $32.3M | $37.2M |
| PP&E | $35.4M | $32.7M |
| Total Liabilities | $216.0M | $247.8M |
| Current Liabilities | $48.6M | $57.5M |
| Shareholders' Equity | $64.7M | $128.8M |
| Retained Earnings | -$404.9M | -$323.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$19.3M | -$78.8M |
| CapEx | $12.9M | $17.9M |
| Investing Cash Flow | $40.3M | $58.2M |
| Financing Cash Flow | -$26.6M | -$27.6M |
| Net Change in Cash | -$5.54M | -$48.2M |
| Free Cash Flow | -$32.2M | -$96.7M |
FAQ
What is ENTA P/E and revenue?
Enanta Pharmaceuticals Inc (ENTA) rev $65.3M.
What is ENTA revenue?
Enanta Pharmaceuticals Inc last cached revenue is $65.3M (FY2025).
Is ENTA profitable?
Enanta Pharmaceuticals Inc last cached net income is -$81.9M (FY2025).
What are ENTA total assets?
Enanta Pharmaceuticals Inc last cached total assets are $280.7M (FY2025).
What is ENTA free cash flow?
Enanta Pharmaceuticals Inc last cached free cash flow is -$32.2M (FY2025).
Not investment advice. Cached statements, not a live tape.